NDC 71610-217 – Hydroxyzine Pamoate

Hydroxyzine Pamoate 25 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC71610-217

Product details

Brand name
Hydroxyzine Pamoate
Generic name
Hydroxyzine Pamoate
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA040156
Marketed since
July 15, 1996
Listing expires
December 31, 2026
Pharmacologic class
Antihistamine

Active ingredients

Uses, dosage, side effects and warnings for Hydroxyzine Pamoate →

Package NDC codes (5)

Package NDCDescriptionSince
71610-217-3030 CAPSULE in 1 BOTTLE, PLASTIC (71610-217-30)Sep 9, 2021
71610-217-5360 CAPSULE in 1 BOTTLE, PLASTIC (71610-217-53)Sep 9, 2021
71610-217-6090 CAPSULE in 1 BOTTLE, PLASTIC (71610-217-60)Jan 7, 2019
71610-217-70120 CAPSULE in 1 BOTTLE, PLASTIC (71610-217-70)Sep 9, 2021
71610-217-80180 CAPSULE in 1 BOTTLE, PLASTIC (71610-217-80)Sep 9, 2021

Other Hydroxyzine Pamoate products